BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21172023)

  • 1. An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1.
    Méndez-Ortega MC; Restrepo S; Rodríguez-R LM; Pérez I; Mendoza JC; Martínez AP; Sierra R; Rey-Benito GJ
    Virol J; 2010 Dec; 7():369. PubMed ID: 21172023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 96 shRNAs designed for maximal coverage of HIV-1 variants.
    McIntyre GJ; Groneman JL; Yu YH; Jaramillo A; Shen S; Applegate TL
    Retrovirology; 2009 Jun; 6():55. PubMed ID: 19497094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ; ter Brake O; Berkhout B
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
    Berkhout B; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag.
    Cave E; Weinberg MS; Cilliers T; Carmona S; Morris L; Arbuthnot P
    AIDS Res Hum Retroviruses; 2006 May; 22(5):401-10. PubMed ID: 16706616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed HIV-1 evolution of protease inhibitor resistance by second-generation short hairpin RNAs.
    Schopman NC; Braun A; Berkhout B
    Antimicrob Agents Chemother; 2012 Jan; 56(1):479-86. PubMed ID: 22064528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.
    Herrera-Carrillo E; Berkhout B
    Gene Ther; 2015 Jun; 22(6):485-95. PubMed ID: 25716532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of extended short hairpin RNAs for HIV-1 inhibition.
    Liu YP; Haasnoot J; Berkhout B
    Nucleic Acids Res; 2007; 35(17):5683-93. PubMed ID: 17715143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference.
    von Eije KJ; ter Brake O; Berkhout B
    J Virol; 2008 Mar; 82(6):2895-903. PubMed ID: 18077712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs.
    Schopman NC; ter Brake O; Berkhout B
    Retrovirology; 2010 Jun; 7():52. PubMed ID: 20529316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation Frequencies in RNAi Targets in HIV-1 Genomes Obtained from Blood Plasma of Patients Receiving Anti-Retroviral Therapy].
    Kretova OV; Gorbacheva MA; Fedoseeva DM; Kravatskya YV; Chechetkin VR; Tchurikov NA
    Mol Biol (Mosk); 2018; 52(4):591-594. PubMed ID: 30113024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Variability in HIV-1 Subtype A Strains in Russia Suggests a Combination of Deep Sequencing and Multitarget RNA Interference for Silencing of the Virus.
    Kretova OV; Chechetkin VR; Fedoseeva DM; Kravatsky YV; Sosin DV; Alembekov IR; Gorbacheva MA; Gashnikova NM; Tchurikov NA
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):194-201. PubMed ID: 27476852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA.
    Pusch O; Boden D; Silbermann R; Lee F; Tucker L; Ramratnam B
    Nucleic Acids Res; 2003 Nov; 31(22):6444-9. PubMed ID: 14602902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.
    Das AT; Brummelkamp TR; Westerhout EM; Vink M; Madiredjo M; Bernards R; Berkhout B
    J Virol; 2004 Mar; 78(5):2601-5. PubMed ID: 14963165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of duplex stability and terminal asymmetry for shRNA design.
    Matveeva OV; Kang Y; Spiridonov AN; Saetrom P; Nemtsov VA; Ogurtsov AY; Nechipurenko YD; Shabalina SA
    PLoS One; 2010 Apr; 5(4):e10180. PubMed ID: 20422034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV.
    Lee SK; Dykxhoorn DM; Kumar P; Ranjbar S; Song E; Maliszewski LE; François-Bongarçon V; Goldfeld A; Swamy NM; Lieberman J; Shankar P
    Blood; 2005 Aug; 106(3):818-26. PubMed ID: 15831707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of HIV-1 by AgoshRNA molecules.
    Herrera-Carrillo E; Harwig A; Berkhout B
    Gene Ther; 2017 Aug; 24(8):453-461. PubMed ID: 28553929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the sequence space available for HIV-1 evolution.
    ter Brake O; von Eije KJ; Berkhout B
    AIDS; 2008 Sep; 22(14):1875-7. PubMed ID: 18753935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.